Enhanced Risk of Type 2 Diabetes Mellitus following treatment with 5a-Reductase Inhibitors

Andrew, Ruth (Principal Investigator)
Walker, Brian (Co-investigator)

Status	Finished
Effective start/end date	1/10/16 → 31/12/17

Funding

UK-based charities: £63,270.00

3 Article

Incidence of type 2 diabetes mellitus in men receiving steroid 5α-reductase inhibitors: population based cohort study
Wei, L., Chia-Cheng Lai, E., Kao-Yang, Y-H., Walker, B. R., MacDonald, T. M. & Andrew, R., 10 Apr 2019, In: British Medical Journal (BMJ). 365, 8196, 11 p., l1204.
Research output: Contribution to journal › Article › peer-review

Open Access
File
Data for analysis of catechol estrogen metabolites in human plasma by liquid chromatography tandem mass spectrometry
Andrew, R., Khan, S., Stasinopoulos, I., Church, C., Homer, N. & McLean, M., 8 Mar 2019, (E-pub ahead of print) In: Data in brief.
Research output: Contribution to journal › Article › peer-review

Open Access
File
Derivatization enhances analysis of estrogens and their bioactive metabolites in human plasma by liquid chromatography tandem mass spectrometry
Denver, N., Khan, S., Stasinopoulos, I., Church, C., Homer, N. ZM., MacLean, M. R. & Andrew, R., 21 Dec 2018, (E-pub ahead of print) In: Analytica Chimica Acta.
Research output: Contribution to journal › Article › peer-review

Open Access
File